Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Kappa opioid receptor agonists

Kappa opioid receptor agonists

US Patent 9303027 · Granted Apr 5, 2016

Estimated economic value: $9,308,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted cycloalkanes for managing nephrogenic diabetes insipidus2025
Piperidine urea derivatives as soluble epoxide hydrolase inhibitors2024
Piperidine urea derivatives as soluble epoxide hydrolase inhibitors2024
Substituted cycloalkanes for managing nephrogenic diabetes insipidus2023
Substituted cycloalkanes for managing nephrogenic diabetes insipidus2021
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/2021
Pyrimido-pyridazinone compounds and methods of use thereof2020
Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibi2019
Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibi2019
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/2019
Pyrimido-pyridazinone compounds and methods of use thereof2019
Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists2018